Exploratory Trial of Navigational Bronchoscopy-Guided Cryoablation in Lung Cancer Treatment

This clinical trial is an exploratory clinical trial with two cohorts: Cohort 1: aiming to conduct a preliminary evaluation of the effectiveness and safety of the Navigational Bronchoscopy System and the Bronchoscope and Accessories (manufactured by Noah) in combination with the cryoablation therapy devices for the treatment of lung malignancies. Cohort 2: aiming to conduct a preliminary evaluation of the effectiveness and safety of the Navigational Bronchoscopy System and the Bronchoscope and Accessories (manufactured by Puli Ark) in combination with the cryoablation therapy devices for the

Trial Details

NCT ID
NCT07301411
Phase
NA
Sponsor
Tianjin Puli Ark Medical Technology Co., Ltd.
Status
RECRUITING
Cancer Type
Lung Cancer
Interventions
  • Cryoablation Therapy
Locations (sample)
  • Shanghai, Shanghai Municipality, China|31.22222,121.45806
  • Shatin, Hong Kong|22.38333,114.18333

Key Eligibility Criteria

  • Aged 18 to 80 years old (inclusive), male or female;
  • Primary peripheral lung cancer, with pre-treatment staging examination indicating clinical stage T1N0M0, IA (including new onset and multiple prima…
  • The maximum diameter of the tumor is ≤3 cm;
  • The number of tumors is ≤3 (no limit for multiple primary lung cancer subjects);

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Lung Cancer Trials on Trialify →